Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 12 2020
Historique:
pubmed: 2 9 2020
medline: 2 2 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

Evidence of whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), can be transmitted as an aerosol (ie, airborne) has substantial public health implications. To investigate potential transmission routes of SARS-CoV-2 infection with epidemiologic evidence from a COVID-19 outbreak. This cohort study examined a community COVID-19 outbreak in Zhejiang province. On January 19, 2020, 128 individuals took 2 buses (60 [46.9%] from bus 1 and 68 [53.1%] from bus 2) on a 100-minute round trip to attend a 150-minute worship event. The source patient was a passenger on bus 2. We compared risks of SARS-CoV-2 infection among at-risk individuals taking bus 1 (n = 60) and bus 2 (n = 67 [source patient excluded]) and among all other individuals (n = 172) attending the worship event. We also divided seats on the exposed bus into high-risk and low-risk zones according to the distance from the source patient and compared COVID-19 risks in each zone. In both buses, central air conditioners were in indoor recirculation mode. SARS-CoV-2 infection was confirmed by reverse transcription polymerase chain reaction or by viral genome sequencing results. Attack rates for SARS-CoV-2 infection were calculated for different groups, and the spatial distribution of individuals who developed infection on bus 2 was obtained. Of the 128 participants, 15 (11.7%) were men, 113 (88.3%) were women, and the mean age was 58.6 years. On bus 2, 24 of the 68 individuals (35.3% [including the index patient]) received a diagnosis of COVID-19 after the event. Meanwhile, none of the 60 individuals in bus 1 were infected. Among the other 172 individuals at the worship event, 7 (4.1%) subsequently received a COVID-19 diagnosis. Individuals in bus 2 had a 34.3% (95% CI, 24.1%-46.3%) higher risk of getting COVID-19 compared with those in bus 1 and were 11.4 (95% CI, 5.1-25.4) times more likely to have COVID-19 compared with all other individuals attending the worship event. Within bus 2, individuals in high-risk zones had moderately, but nonsignificantly, higher risk for COVID-19 compared with those in the low-risk zones. The absence of a significantly increased risk in the part of the bus closer to the index case suggested that airborne spread of the virus may at least partially explain the markedly high attack rate observed. In this cohort study and case investigation of a community outbreak of COVID-19 in Zhejiang province, individuals who rode a bus to a worship event with a patient with COVID-19 had a higher risk of SARS-CoV-2 infection than individuals who rode another bus to the same event. Airborne spread of SARS-CoV-2 seems likely to have contributed to the high attack rate in the exposed bus. Future efforts at prevention and control must consider the potential for airborne spread of the virus.

Identifiants

pubmed: 32870239
pii: 2770172
doi: 10.1001/jamainternmed.2020.5225
pmc: PMC7489377
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1665-1671

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Auteurs

Ye Shen (Y)

Department of Epidemiology and Biostatistics, University of Georgia College of Public Health, Athens.

Changwei Li (C)

Department of Epidemiology and Biostatistics, University of Georgia College of Public Health, Athens.
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.

Hongjun Dong (H)

Ningbo Municipal Center for Disease Control and Prevention, Ningbo, China.

Zhen Wang (Z)

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Leonardo Martinez (L)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California.

Zhou Sun (Z)

Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou, China.

Andreas Handel (A)

Department of Epidemiology and Biostatistics, University of Georgia College of Public Health, Athens.
Health Informatics Institute, University of Georgia College of Public Health, Athens.
Center for the Ecology of Infectious Diseases, University of Georgia, Athens.

Zhiping Chen (Z)

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Enfu Chen (E)

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Mark H Ebell (MH)

Department of Epidemiology and Biostatistics, University of Georgia College of Public Health, Athens.

Fan Wang (F)

Renmin University of China School of Statistics, Beijing, China.
Statistical Consulting Center, Renmin University of China, Beijing, China.

Bo Yi (B)

Ningbo Municipal Center for Disease Control and Prevention, Ningbo, China.

Haibin Wang (H)

Haishu Center for Disease Control and Prevention, Ningbo, China.

Xiaoxiao Wang (X)

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Aihong Wang (A)

Ningbo Municipal Center for Disease Control and Prevention, Ningbo, China.

Bingbing Chen (B)

Haishu Center for Disease Control and Prevention, Ningbo, China.

Yanling Qi (Y)

Department of Health Care Administration, California State University Long Beach, College of Health and Human Services, Long Beach.

Lirong Liang (L)

Department of Clinical Epidemiology and Tobacco Dependence Treatment Research, Beijing Chaoyang Hospital, Beijing, China.

Yang Li (Y)

Renmin University of China School of Statistics, Beijing, China.
Statistical Consulting Center, Renmin University of China, Beijing, China.
Center for Applied Statistics, Renmin University of China, Beijing, China.

Feng Ling (F)

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Junfang Chen (J)

Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou, China.

Guozhang Xu (G)

Ningbo Municipal Center for Disease Control and Prevention, Ningbo, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH